Faes Farma, S.A. Stock price

Equities

FAE

ES0134950F36

Pharmaceuticals

Real-time Estimate Tradegate 06:39:11 2024-02-29 am EST 5-day change 1st Jan Change
2.99 EUR 0.00% Intraday chart for Faes Farma, S.A. -0.50% -5.38%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 451M 489M Sales 2024 * 465M 504M Capitalization 939M 1.02B
Net income 2023 91M 98.67M Net income 2024 * 86M 93.24M EV / Sales 2023 2.2 x
Net Debt 2023 * 33.3M 36.11M Net cash position 2024 * 42M 45.54M EV / Sales 2024 * 1.93 x
P/E ratio 2023 *
10.9 x
P/E ratio 2024 *
10.8 x
Employees 1,764
Yield 2023 *
3.93%
Yield 2024 *
4.68%
Free-Float 90.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.17%
1 week-0.67%
Current month-1.97%
1 month-1.32%
3 months-4.94%
6 months-8.44%
Current year-5.54%
More quotes
1 week
2.97
Extreme 2.965
3.08
1 month
2.95
Extreme 2.95
3.09
Current year
2.95
Extreme 2.95
3.27
1 year
2.87
Extreme 2.865
3.44
3 years
2.87
Extreme 2.865
4.29
5 years
2.87
Extreme 2.865
5.48
10 years
1.61
Extreme 1.6127
5.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - -
Director of Finance/CFO - -
Members of the board TitleAgeSince
Chairman - 91-05-15
Director/Board Member - 94-06-25
Director/Board Member - 03-06-23
More insiders
Date Price Change Volume
24-02-29 2.99 0.00% 157 246
24-02-28 2.99 -2.92% 142,109
24-02-27 3.08 +1.48% 158,521
24-02-26 3.035 +0.66% 195,688
24-02-23 3.015 +0.33% 194,507

Delayed Quote BME, February 29, 2024 at 05:40 am EST

More quotes
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company's research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
2.99 EUR
Average target price
3.708 EUR
Spread / Average Target
+24.00%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Faes Farma, S.A. - BME
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW